Modeling preventative strategies against human papillomavirus-related disease in developed countries

K Canfell, H Chesson, SL Kulasingam, J Berkhof… - Vaccine, 2012 - Elsevier
Over the last 5 years, prophylactic vaccination against human papillomavirus (HPV) in pre-
adolescent females has been introduced in most developed countries, supported by …

Public health value of universal HPV vaccination

RA Audisio, G Icardi, AM Isidori, CA Liverani… - Critical reviews in …, 2016 - Elsevier
Abstract Background The story of Human Papillomavirus vaccination demands reflection not
only for its public health impact on the prophylactic management of HPV disease, but also …

[HTML][HTML] Estimation of the potential overall impact of human papillomavirus vaccination on cervical cancer cases and deaths

G Van Kriekinge, X Castellsagué, D Cibula… - Vaccine, 2014 - Elsevier
Background Human papillomavirus (HPV) vaccination offers potential for primary prevention
of HPV-related pre-cancers and cancers as demonstrated in clinical trials. Mathematical …

Cost-effectiveness of human papillomavirus vaccination in Germany

O Damm, J Horn, RT Mikolajczyk… - Cost Effectiveness and …, 2017 - Springer
Background The aim of this study was to assess the cost-effectiveness of human
papillomavirus (HPV) vaccination in addition to the current cervical cancer screening …

An estimate of the public health impact and cost-effectiveness of universal vaccination with a 9-valent HPV vaccine in Germany

N Largeron, KU Petry, J Jacob, F Bianic… - Expert review of …, 2017 - Taylor & Francis
ABSTRACT Introduction: Since 2007, the German Standing Vaccination Committee
recommends HPV vaccination for girls aged 12–17 with a 2-(Cervarix®) or 4-valent …

Estimating the long-term effects of HPV vaccination in Germany

J Horn, O Damm, MEE Kretzschmar, Y Deleré… - Vaccine, 2013 - Elsevier
In Germany, vaccination against the most oncogenic HPV types 16/18 is recommended by
the Standing Committee on Vaccination (STIKO) for 12–17 year old girls since March 2007 …

Universal vaccination with the quadrivalent HPV vaccine in Austria: impact on virus circulation, public health and cost–effectiveness analysis

X Bresse, C Goergen, B Prager… - Expert review of …, 2014 - Taylor & Francis
The International Agency for Research on Cancer acknowledges that HPV is a human
carcinogen affecting both sexes. This study aimed to evaluate the public health impact of …

[HTML][HTML] How and why researchers use the number needed to vaccinate to inform decision making—A systematic review

A Hashim, V Dang, S Bolotin, NS Crowcroft - Vaccine, 2015 - Elsevier
Background The number needed to vaccinate (NNV) is a measure that has been widely
used in the scientific literature to draw conclusions about the usefulness and cost …

A dynamic Bayesian Markov model for health economic evaluations of interventions in infectious disease

K Haeussler, A den Hout, G Baio - BMC Medical Research Methodology, 2018 - Springer
Background Health economic evaluations of interventions in infectious disease are
commonly based on the predictions of ordinary differential equation (ODE) systems or …

Economic evaluation of human papilloma virus vaccination in the European Union: a critical review

D Koleva, P De Compadri, A Padula… - Internal and emergency …, 2011 - Springer
The human papilloma virus (HPV) vaccine is a new and expensive vaccine potentially
effective in the prevention of a cancer. We reviewed the economic evaluations (EEs) on the …